Cipla Opens First Breathefree Lung Wellness Centre in Delhi
Cipla launches India's first integrated lung diagnostics center in New Delhi, revolutionizing respiratory care with advanced, affordable testing to combat rising lung diseases.
Category : Search result: Cipla
SBI, Adani, Airtel, Cipla: 10 Stocks to Watch Today
Get expert analysis on today's top stock market movers including SBI, Adani Enterprises, Bharti Airtel, and Cipla. Discover key triggers, technical levels, and trading strategies for 10 high-impact shares.
Cipla CEO Change: Achin Gupta Succeeds Umang Vohra
Indian pharmaceutical giant Cipla reveals strategic leadership transition with Achin Gupta succeeding Umang Vohra as Global CEO in September 2024, marking a new era for the company.
Cipla Shares Fall 4% After Q2 Results
Cipla's stock faced significant pressure after Q2 FY2025 results revealed margin pressures despite revenue growth. Discover the key factors behind the 4% decline and what analysts are saying about the pharmaceutical giant's future prospects.
FSSAI's ORS Rules: Cipla Prolyte is Asli ORS
Cipla Health welcomes FSSAI's stringent ORS labelling regulations, positioning Prolyte ORS as the authentic electrolyte solution for dehydration management in India.
Cipla Shares Fall 3% Despite Eli Lilly Weight Loss Drug Deal
Cipla's stock faces unexpected pressure despite securing rights to manufacture and distribute Eli Lilly's revolutionary weight loss drug Mounjaro in India. Discover why investors remain cautious.
Lilly-Cipla Partnership Expands Weight Loss Therapy Access
In a groundbreaking move, Eli Lilly partners with Cipla to dramatically expand availability of innovative weight loss therapies across India, addressing the growing obesity crisis.
Cipla-Eli Lilly deal brings weight loss drugs to India
Indian pharmaceutical giant Cipla announces landmark deal with Eli Lilly to manufacture and distribute popular weight loss medications Mounjaro and Zepbound in India under different brand names.
Eli Lilly-Cipla Partner for Weight Loss Drugs in India
Pharma giant Eli Lilly collaborates with Indian partner Cipla to introduce groundbreaking obesity and diabetes treatments Mounjaro and Yurpeak in the Indian market, expanding access to innovative weight management solutions.
Muhurat Trading 2023: Top Gainers & Losers Revealed
Discover the top performers and laggards from Diwali's Muhurat Trading session 2023. Bajaj Finserv, Cipla, and Axis Bank emerged as star gainers while DCB Bank faced headwinds in this special one-hour trading event.
Page 1 of 1